[1]
N. A. e Lima and R. C. F. de Vasconcelos, “THE DEVELOPMENT OF TELOGEN EFFLUVIUM POST-COVID-19 AND ITS IMPLICATIONS IN PATIENTS WITH PREVIOUS ALOPECIA”, REASE, vol. 10, no. 10, pp. 5095–5102, Oct. 2024, doi: 10.51891/rease.v10i10.16385.